Implications for Nitric Oxide Synthesis |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
Abstract |
|---|
|
|
|---|
Eosinophil-derived cationic proteins play an essential role in the pathogenesis of bronchial asthma. We
tested whether cationic proteins interfere with the cationic amino-acid transport in alveolar macrophages
(AM
) and tracheal epithelial cells, and whether L-arginine-dependent pathways were affected. The effect
of cationic polypeptides on cellular uptake of [3H]-L-arginine, nitrite accumulation, and the turnover of
[3H]-L-arginine by nitric oxide (NO) synthase and arginase (formation of [3H]-L-citrulline and [3H]-L-ornithine, respectively) were studied. Poly-L-arginine reduced [3H]-L-arginine uptake in rat AM
and tracheal
epithelial cells in a concentration-dependent manner (at 300 µg/ml by 70%). Poly-L-lysine, protamine, and
major basic protein (each up to 300 µg/ml) tested in rat AM
inhibited [3H]-L-arginine uptake by 35 to
50%. During 6 h incubation in amino acid-free Krebs solution, rat AM
, precultured in the absence or
presence of LPS (1 µg/ml), accumulated 1.4 and 3.5 nmol/106 cells nitrite, respectively. Addition of 100 µM L-arginine increased nitrite accumulation by 70 and 400% in control and lipopolysaccharide-treated AM
, respectively. Nitrite accumulation in the presence of L-arginine was reduced by poly-L-arginine and
poly-L-lysine (100 and 300 µg/ml) by 60 to 85% and 20 to 30%, respectively. Poly-L-arginine, but not
poly-L-lysine, inhibited nitrite accumulation already in the absence of extracellular L-arginine. Poly-L-arginine (300 µg/ml) inhibited [3H]-L-citrulline formation by AM
stronger than that of [3H]-L-ornithine. We
conclude that cationic proteins can inhibit cellular transport of L-arginine and this can limit NO synthesis. Poly-L-arginine inhibits L-arginine uptake more effectively than other cationic proteins and exerts additional direct inhibitory effects on NO synthesis.
| |
Introduction |
|---|
|
|
|---|
Eosinophilic infiltration is a major characteristic of allergic airway diseases, and appears to play a key role in the development of asthmatic airway diseases. Eosinophils contain several granules associated with cationic polypeptides such as major basic protein (MBP) and eosinophilic cationic peptide (ECP), and these charged peptides are released upon activation of the eosinophils (1, 2). There is substantial experimental evidence suggesting that eosinophils and particularly their cationic proteins play an essential role in the pathogenesis of airway hyperresponsiveness in bronchial asthma (3, 4). Thus, intratracheal instillation of MBP or ECP can cause airway hyperresponsiveness and these effects can be mimicked by the synthetic cationic proteins poly-L-arginine and poly-L-lysine, suggesting that charge interactions might be important (5).
On the other hand, it has been shown that inhibition of L-arginine-dependent nitric oxide (NO) synthesis can cause airway hyperresponsiveness (8), and there is evidence that deficiency in the L-arginine/NO pathway could be one mechanism responsible for the development of airway hyperresponsiveness under pathologic conditions (9, 10).
In this context it should be noted that the intracellular availability of L-arginine can be a limiting factor for the synthesis of NO (11). One important factor determining the intracellular concentration of L-arginine is the cellular uptake of L-arginine, which is mediated via specific cationic amino-acid transport systems (12, 13). It appeared to be an interesting idea that eosinophil-derived cationic proteins could interfere with the cationic amino-acid transporter, thereby reducing the cellular availability of L-arginine, and as a consequence inhibiting L-arginine-dependent mediator synthesis, such as NO.
In the present study the effect of cationic proteins on
the uptake of L-arginine in alveolar macrophages (AM
)
and tracheal epithelial cells was studied, because these
cells can express an inducible form of NO synthase (iNOS)
(e.g., 14-17). This enzyme is particularly dependent on extracellular L-arginine supply (11, 18) and, among others,
appears to play a role in the control of local immune reactions (e.g., 19-21). Because biologic effects of MBP could
be mimicked by synthetic cationic proteins such as poly-L-arginine and poly-L-lysine (6, 7), and because on the other
hand, the available quantities of eosinophil-derived cationic proteins are very limited, most of the present experiments were carried out using synthetic cationic proteins.
A preliminary account of the present study was given at the Winter Meeting of the British Pharmacological Society (22).
| |
Materials and Methods |
|---|
|
|
|---|
Preparation and Culture of AM
and
Tracheal Epithelial Cells
Sprague Dawley rats (own breeding; University of Bonn,
Bonn, Germany) of either sex were killed by stunning followed by exsanguination. Lung and trachea were excised
en bloc, washed with calcium- and magnesium-free Dulbecco's phosphate-buffered saline (D-PBS) and lavaged
three times by instilling about 15 ml of cold (4°C) D-PBS. Usually for one preparation of AM
, lavage fluids of four
or five lungs were pooled and centrifuged at 400 × g for
5 min. The cells were washed three times with D-PBS and
thereafter resuspended in Dulbecco's modified Eagle's
medium (DMEM)/Ham's F-12 medium supplemented
with 5% fetal calf serum (FCS), 100 U/ml penicillin, 100 µg/ml streptomycin, and 5 µg/ml amphotericin B and
plated (2.5 × 106 cells/well for turnover studies and 3 × 106 cells/well for uptake studies) in sterile six-well dishes
or 0.5 × 106 cells/well for nitrite accumulation studies in
24-well dishes (NUNC, Wiesbaden, Germany). The AM
were allowed to adhere for 2 h (37°C, 5% CO2). After 2 h
the medium was renewed to remove nonadherent cells.
The adherent cells consisted of more than 95% AM
according to morphologic criteria (May Grünwald Giemsa
staining). Thereafter, cells were cultured for 20 h in the absence or presence of lipopolysaccharides (LPS; 1 µg/ml)
followed by L-arginine uptake, turnover, or nitrite accumulation studies. Cell viability assessed by trypan blue exclusion was always greater than 95%.
Tracheal epithelial cells of newborn rats were cultured using the explant technique as described previously (17), with the modification that RPMI-1640 medium with reduced calcium (60 to 80 µmol/liter) was used only during the outgrowth phase to ensure the selective outgrowth of epithelial cells from tracheal explant, but for subsequent passages DMEM/Ham's F-12 medium containing standard calcium concentration was used. The culture media also contained 5% FCS and were supplemented with 20 ng/ml epidermal growth factor, 1 µM hydrocortisone, 10 µg/ml insulin, 5 µg/ml transferrin, 100 U/ml penicillin, and 100 µg/ml streptomycin. In the present study confluent monolayers of the 8th to 12th passage were used to study L-arginine uptake. Confluency was reached usually between 7 and 10 d after dissemination of the cells.
Measurement of [3H]-L-Arginine Uptake and Turnover
In [3H]-L-arginine uptake studies, AM
cultured for 20 h
or confluent epithelial cultures were incubated at 37°C for
2 min in 1 ml [3H]-L-arginine (37 kBq, 0.1 µM) containing
Krebs-N-2-hydroxyethylpiperazine-N'-ethane sulfonic acid
(Hepes solution [composition, in mM: NaH2PO4 0.001; NaCl 118.5; KCl 5.57; CaCl2 1.25; MgCl2 1.2; Na2-ethylenediaminetetraacetic acid (Na2EDTA) 0.03; L-(+) ascorbic
acid 0.06; Hepes 20.0 (adjusted to pH 7.4 using NaOH);
and D-(+)-glucose 11.1]) in the absence or presence of
polycations, followed by determination of the cellular radioactivity, as described previously (23, 24). The 2-min incubation period was chosen because [3H]-L-arginine accumulation was linear between 1 and 3 min (23, 24). [3H]-L-arginine uptake was expressed either in absolute terms
(dpm/3 × 106 cells) or as the percentage of the uptake observed in controls of the respective cell preparations.
In the turnover studies, AM
(2.5 × 106 cells, cultured
for 20 h in the absence or presence of 1 µg/ml LPS) were
incubated at 37°C for 1 h in 1 ml [3H]-L-arginine (37 kBq,
0.1 µM) containing Krebs-Hepes solution in the absence
or presence of cationic proteins. The incubation media
were collected and kept at
20°C until analyzed by high-performance liquid chromatography (HPLC) (see below).
Measurement of Nitrite Accumulation
For nitrite accumulation studies, AM
, 0.5 × 106 cells,
cultured for 20 h in the absence or presence of 1 µg/ml
LPS were washed and incubated at 37°C for 6 h in 0.5 ml
Krebs-Hepes solution with or without L-arginine (0.1 mM) and additionally poly-L-arginine or poly-L-lysine.
The incubation media were collected and kept at
80°C
until the accumulated amounts of nitrite were determined.
Nitrite (NO2
) was determined in cell-free supernatants of the 6-h incubation period by a spectrophotometric
assay based on the Griess reaction. The amount of 400 µl
Griess reagent (sulfanilamide 1%, N[1-naphthyl]ethylenediamine hydrochloride 0.1% dissolved in 2.5% [wt/vol]
H3PO4) were added to 400 µl incubation medium. After 20 min of incubation at room temperature, absorbance was measured at 540 nm. The nitrite contents given under RESULTS were calculated from a standard curve (NaNO2) and
expressed as nanomoles of nitrite (per 106 cells/6 h).
HPLC Analysis
[3H]-labeled L-citrulline, L-ornithine, and L-arginine present in incubation media were separated as described previously (14) on a reverse-phase column (length, 250 mm; inner diameter, 4.6 mm; prepacked with Shadon ODS-Hypersil, 5 µm), using as mobile phase a 0.1 M sodium phosphate buffer (adjusted to pH 1.8) that contained octane sulfonic acid sodium salt (400 mg/liter), Na2EDTA (0.3 mM), and methanol (6% vol/vol) with a flow rate of 1 ml/ min and 1.5 ml/min for the initial 30 and the following 90 min, respectively. The HPLC eluate was collected in 1-min fractions into counting vials. The retention time of amino acids was determined by the use of [14C]-labeled L-citrulline and L-ornithine or [3H]-labeled L-arginine as standards. L-Citrulline, L-ornithine and L-arginine eluted after 7 to 8 min, 12 to 13 min, and about 70 min, respectively. The amounts of radiolabeled amino acids in the media were expressed either in absolute terms (dpm/2.5 × 106 cells) or as the percentage of values observed in controls of the respective cell preparations.
Drugs and Special Chemicals
Amphotericin B, L-arginine HCl, D-PBS, DMEM/Ham's
F-12 medium, epidermal growth factor, hydrocortisone, insulin, LPS from Escherichia coli 0127:B8, penicillin-streptomycin solution, poly-L-arginine (MW 5,000-15,000),
poly-L-aspartate (MW 5,000-15,000), poly-L-lysine (MW
4,000-15,000), pronase, protamine, and transferrin were
all from Sigma, München, Germany. L-[2,3-3H]-arginine
HCl (36 to 40 Ci/mmol) was from Sigma or Dupont, Dreieich, Germany. Calcium-free RPMI-1640 medium was
from Serva, and FCS from Vitromex, Germany. MBP was
purified from eosinophils obtained from patients with
marked eosinophilia as previously described (25). In brief,
eosinophils were lysed with sucrose and heparin and granules were isolated by centrifugation. Granules were lysed by exposure to 0.01 M HCl, pH 2, and by sonication. Granule extracts were applied to a 1.2 × 47 cm Sephadex G-50
column that had been equilibrated with 0.025 M sodium
acetate and 0.15 M NaCl, pH 4.3. The fractions from the
third peak were pooled as MBP, stored at
70°C, and
thawed immediately before use. MBP was pure as judged by the banding pattern on sodium dodecyl sulfate polyacrylamide gel electrophoresis after staining with Coomassie brilliant blue R.
Statistics
All values are means ± standard error of the mean (SEM) of n experiments. Statistical significance of differences was evaluated by Student's t test. When multiple comparisons were performed, the significance of differences was evaluated by analysis of variance followed by the modified t test according to Bonferroni using the computer program GraphPad InStat (GraphPad Software, San Diego, CA).
| |
Results |
|---|
|
|
|---|
Effects of Cationic Proteins on [3H]-L-Arginine
Uptake in AM
Under control conditions, rat AM
incubated for 2 min
with [3H]-L-arginine (37 kBq/ml, 0.1 µM) accumulated
20,238 ± 2,521 dpm/(3 × 106 cells), corresponding to 1.30 ± 0.16 pmol L-arginine/(3 × 106 cells) (n = 22). The different
cationic proteins, poly-L-arginine, poly-L-lysine, protamine, and MBP, present in the incubation medium (i.e.,
during the uptake period) inhibited [3H]-L-arginine uptake
in a concentration-dependent manner (Figure 1, Table 1).
Poly-L-arginine was more potent than the other cationic proteins and caused an inhibition by about 80% at the
highest concentration tested (300 µg/ml). The inhibition
produced by 300 µg/ml of the other cationic proteins
tested was between 40 and 50% for poly-L-lysine and protamine and 35% for MBP.
|
|
Heparin (100 µg/ml) present together with the cationic
proteins blocked the inhibitory effect of poly-L-arginine
(30 and 100 µg/ml, Figure 1) as well as that of poly-L-lysine
(30 and 100 µg/ml, data not shown, each n = 6). Heparin
(100 µg/ml) alone did not affect [3H]-L-arginine uptake in
rat AM
(n = 6, data not shown). Likewise, poly-L-aspartate (300 µg/ml), as an example of anionic protein, did not
affect [3H]-L-arginine uptake in rat AM
(n = 6, data not shown).
After 20 h culture in the presence of LPS (1 µg/ml)
[3H]-L-arginine uptake in rat AM
was enhanced to
70,031 ± 10,807 dpm/(3 × 106 cells) (n = 6). Poly-L-arginine (100 and 300 µg/ml) reduced [3H]-L-arginine uptake
to 38 ± 4 and 21 ± 3%, respectively (each n = 6); i.e.,
poly-L-arginine caused similar effects as those in AM
cultured in the absence of LPS (see Table 1). On the other hand, poly-L-lysine (100 and 300 µg/ml) reduced [3H]-L-arginine uptake only to 91 ± 10 and 74 ± 5%, respectively (each n = 6); i.e., the inhibitory potency of poly-L-lysine
appeared to be reduced after LPS treatment (compared
with AM
cultured in the absence of LPS; see Table 1).
Effects of Cationic Proteins on [3H]-L-Arginine Uptake in Tracheal Epithelial Cells
Because the characteristics of [3H]-L-arginine uptake in tracheal epithelial cells (in contrast to AM
) have not been
described in previous studies, some basic observations of
this uptake are described first. During 2 min of incubation
with [3H]-L-arginine under control conditions, confluent
rat tracheal epithelial cells accumulated 34,180 ± 5,058 dpm/well (n = 29), corresponding to 2.20 ± 0.32 nmol
L-arginine. The accumulation of [3H]-L-arginine showed a
linear time dependency between 1 and 5 min and reached
a plateau between 10 and 20 min, which was about 3- to 4-fold higher than the 2-min value (Figure 2A). The uptake of [3H]-L-arginine was not affected when extracellular sodium ions were replaced by equimolar choline and was inhibited by about 95% by 1 mM L-lysine, but was not affected by the neutral amino acid L-leucine (0.1 and 1 mM)
(Figure 2B). Thus, the transport of L-arginine uptake
showed typical characteristics of the cationic amino-acid
transport system y+ (see Reference 12).
|
As in AM
, poly-L-arginine showed marked inhibitory
effects on [3H]-L-arginine uptake in rat tracheal epithelial
cells; at the highest concentration tested (300 µg/ml), poly-
L-arginine inhibited [3H]-L-arginine uptake by 65% (Figure 3). Again, this effect of poly-L-arginine was prevented
by 100 µg/ml heparin (Figure 3), which alone had no effect
(data not shown). As in AM
, poly-L-lysine was less effective than poly-L-arginine in inhibiting [3H]-L-arginine uptake, and the inhibition seen at the maximum concentration (300 µg/ml) tested was about 40% (data not shown).
|
Effects of Polycations on Nitrite Formation
by Rat AM
The effect of poly-L-arginine and poly-L-lysine on the accumulation of nitrite (as a measure of NO synthesis) was
studied. When rat AM
, after culture in the absence of
LPS, were incubated for 6 h in amino acid-free Krebs solution, only a small amount of nitrite (1.37 ± 0.14 nmol)
accumulated in the medium and addition of 100 µM L-arginine caused an increase by 70% (Figure 4). When LPS-stimulated AM
were incubated, the nitrite accumulation
in the absence of L-arginine was 3.48 ± 0.29 nmol and addition of L-arginine (100 µM) increased nitrite accumulation about 4-fold (Figure 4). When poly-L-arginine (100 and 300 µg/ml) was added, nitrite accumulation in the absence of L-arginine was reduced by about 40 to 50% both
in control and LPS-treated AM
(Figures 5A and 5C). In
the presence of L-arginine (100 µM) the inhibitory effect
of poly-L-arginine on nitrite accumulation was more pronounced; an inhibition by about 60 and 85% was caused by
100 µg/ml poly-L-arginine in control and LPS-treated
AM
, respectively (Figures 5B and 5D). Notably, 30 µg/
ml poly-L-arginine, which caused an inhibition of [3H]-L-arginine uptake by about 50% (Table 1), inhibited nitrite accumulation in L-arginine-containing medium by about
30% in control AM
but by about 80% in LPS-treated
AM
(Figures 5B and 5D). On the other hand, poly-L-lysine had no clear effect on nitrite accumulation in the absence of L-arginine, both in control and LPS-treated AM
(Figures 5A and 5C), but in the presence of L-arginine
(100 µM) we observed a significant inhibition by about 30 and 20% in control and LPS-treated AM
, respectively
(Figures 5B and 5D).
|
|
Effects of Cationic Proteins on [3H]-L-Arginine
Metabolism by NOS and Arginase in Rat AM
As already observed in previous studies (14, 23), when rat
AM
that had been cultured for 20 h under control conditions were incubated for 1 h in Krebs medium containing
[3H]-L-arginine (37 kBq/ml, 0.1 µM), a significant accumulation of [3H]-L-citrulline and [3H]-L-ornithine occurred in
the incubation medium (Figures 6 and 7). The amount of
radioactivity found in the [3H]-L-citrulline and [3H]-L-ornithine fractions corresponded to 6.7 ± 1.1 and 9.8 ± 0.7% of the total radioactivity of the incubation media, respectively. Poly-L-arginine present during the 1-h incubation
period inhibited in a concentration-dependent manner the
formation of [3H]-L-citrulline and [3H]-L-ornithine. However, the effects on [3H]-L-citrulline formation were more
pronounced than those on [3H]-L-ornithine formation
(Figure 6). When the AM
were cultured in the presence
of LPS, accumulation of [3H]-L-citrulline increased about
7-fold and this was accompanied by 80% reduction in
[3H]-L-ornithine formation (Figure 7). Under these conditions, poly-L-arginine again reduced in a concentration-
dependent manner the formation of [3H]-L-citrulline even
below the level of untreated AM
(not exposed to LPS)
(Figure 7). This was accompanied by an increase in [3H]-L-ornithine formation, which, however, did not reach the
level observed in untreated AM
.
|
|
| |
Discussion |
|---|
|
|
|---|
It has been shown that cationic proteins, both the naturally occuring eosinophil-derived MBP and ECP as well as the synthetic peptides poly-L-arginine and poly-L-lysine, can cause airway hyperresponsiveness (5). In addition, cationic proteins can exert cytotoxic effect to airway epithelial cells (26, 27) and cause epithelial changes similar to those observed in bronchial asthma (28). Therefore, it has been suggested that epithelial damage caused by these charged proteins may be a major mechanism responsible for the development of airway hyperresponsiveness in asthma. On the other hand, there is increasing evidence that cationic proteins can also alter airway functions through "non-cytotoxic" mechanisms. Thus, hyperresponsiveness after exposure to cationic proteins is observed already within 1 h, i.e., long before any morphologic damage to the epithelium is observed, and there is additional evidence suggesting that cationic proteins may affect the release of epithelium-derived factors that modulate the responsiveness of airway smooth muscle (29). In addition, cationic proteins appear to activate sensory nerves (32), to liberate bradykinin (33), and to enhance parasympathetic neurotransmission (34).
The present experiments show that cationic proteins
can inhibit the cellular uptake of L-arginine, and this effect
was observed in AM
and tracheal epithelial cells (i.e., in
two different cell types present in the airway mucosa).
Further, it may be mentioned that effects similar to those
described here for rat AM
and tracheal epithelial cells
were also observed in AM
and tracheal epithelial cells of
the guinea pig (22, and data not shown), suggesting a general biologic significance of the described effects. Like
other biologic effects of cationic proteins, their effects on
the uptake of L-arginine were prevented by heparin, indicating that the positive charge is important for the effects
on L-arginine transport.
It appears that poly-L-arginine is more potent than
poly-L-lysine in inhibiting L-arginine transport. The most
detailed experiments in the present studies were carried
out on AM
, and here it was additionally shown that
MBP also reduced L-arginine uptake, as did protamine, an
endogenous but commercially available cationic protein
that may also be used in in vitro studies to substitute for
MBP (e.g., 35). The magnitude of the effects of protamine and MBP were comparable to that of poly-L-lysine but
smaller than that of poly-L-arginine. The potency of MBP
in the present in vitro experiments might have been underestimated for several reasons. MBP is known to precipitate from saline at physiologic pH, but for the present uptake studies the cells have to be incubated in a physiologic
salt solution. In addition, MBP may adhere to the surface
of the culture dish. Such an adsorptive loss could have
been minimized by pre-exposure of the culture dish to
poly-L-lysine, but poly-L-lysine showed to be an effective
inhibitor of L-arginine uptake on its own and therefore
could not be used for this purpose.
Because poly-L-arginine was a more effective inhibitor
of L-arginine uptake than were the other cationic peptides,
it may be concluded that, in addition to the positive
charge, specific chemical structures (related to L-arginine)
appear to enhance the affinity to the transport system and
the inhibitory potency. After exposure to LPS, a treatment
which causes marked induction of iNOS and as a consequence increases L-arginine demand, L-arginine uptake
into AM
was enhanced. Most interestingly, this was accompanied by some reduction in the potency of poly-L-lysine, but not of poly-L-arginine, to inhibit L-arginine uptake. Thus, after exposure to LPS the cationic amino-acid
transport system in AM
appears to develop a higher degree of "L-arginine specificity."
Although in the mammalian organism L-arginine is not
an essential amino acid, this amino acid can be synthesized
only by some mammalian cells, whereas many other cells
in the mammalian organism appear to depend on the L-arginine supply from extracellular sources. Thus, NO synthesis
in rat AM
, particularly after marked induction of iNOS,
largely depends on an exogenous supply of L-arginine (18);
this is confirmed in the present study (Figure 4). Tracheal epithelial cells may also depend on an exogenous L-arginine supply. Although we observed that rat tracheal epithelial cells could synthesize some L-arginine from L-citrulline, the turnover rate of this pathway was so small that it
may not be a way to supply the cells sufficiently with L-arginine (unpublished observations), particularly not under
conditions of enhanced need such as induction of NO synthesis or cell proliferation. In line with this conclusion are
recent observations that the activity of the L-arginine
transport in proliferating tracheal epithelial cells in culture
is much higher than that in confluent cultures (36).
The cellular uptake of L-arginine is mediated via specific cationic amino-acid transporters (12, 13), which, in addition to L-arginine, also transport other cationic amino acids such as L-ornithine and L-lysine, the latter being an essential amino acid. Thus, inhibitory effects on cationic amino-acid transporters may reduce the cellular availability of several cationic amino acids and therefore may have multiple functional consequences. Because L-lysine and L-arginine are involved in protein synthesis, prolonged inhibition of cationic amino-acid transport could result in a disturbed protein synthesis. Further, L-arginine is the substrate in two pathways generating important cellular and transcellular mediators, the NO synthase and the arginase-polyamine pathways. Therefore, L-arginine deficiency may result in a reduced synthesis of NO and of ornithine that serves as a precursor for the synthesis of polyamines (37). In contrast, to effects on protein synthesis, inhibitory actions of cationic proteins on the cationic amino-acid transports may affect these mediator pathways immediately.
Indeed, the present experiments also show that poly-L-arginine and poly-L-lysine can cause an acute reduction of
nitrite accumulation by rat AM
. Here again, the inhibitory effect of poly-L-arginine was more pronouced than
that of poly-L-lysine. As already mentioned, the NO synthesis by rat AM
largely depends on the cellular uptake of L-arginine. When rat AM
were incubated in amino
acid-free Krebs solution, their cellular L-arginine availability appeared to be immediately at a level suboptimal
for NO synthesis, particularly when the iNOS had been
markedly induced by pre-exposure of the cells to LPS, and
addition of L-arginine caused a marked increase in NO
synthesis (Figure 4). Poly-L-lysine inhibited nitrite accumulation only in the experiments in which L-arginine was
present (Figures 5B and 5D), i.e., when part of the NO
synthesis depended directly on the cellular uptake of L-arginine, indicating that the inhibitory effect of poly-L-lysine
on L-arginine uptake is of functional consequences for the
NO synthesis. On the other side, an inhibitory effect of
poly-L-arginine on nitrite accumulation was already observed in the absence of L-arginine, suggesting that this
cationic protein may exert additional direct inhibitory effects on NO synthesis. The additional direct inhibitory effects of poly-L-arginine on NO synthesis appear to be of
particular significance after marked induction of iNOS.
Thus, in AM
not exposed to LPS and incubated in L-arginine-containing medium, poly-L-arginine and poly-L-lysine in concentrations producing similar inhibiton of L-arginine
uptake (30 and 300 µg/ml, respectively; Table 1) were almost equally effective in reducing nitrite accumulation
(Figure 5B); whereas in LPS-treated AM
, 30 µg/ml poly-
L-arginine caused a substantially larger reduction of nitrite
accumulation than did 300 µg/ml poly-L-lysine (Figure 5D).
The significance of a direct inhibition of NO synthesis
by poly-L-arginine is further supported by the observations
on the metabolism of [3H]-L-arginine (Figures 6 and 7).
Rat AM
cultured in the absence of LPS and incubated
for 1 h in Krebs medium containing [3H]-L-arginine showed
a significant formation of [3H]-L-citrulline and [3H]-L-ornithine, as measures of NOS and arginase activity, respectively. Addition of poly-L-arginine to the incubation medium resulted in a concentration-dependent reduction in
the formation of [3H]-L-citrulline and [3H]-L-ornithine, the
effect on [3H]-L-citrulline being more pronounced than
that on [3H]-L-ornithine. Inhibitory effects of poly-L-arginine on L-arginine transport may account for the reduction
of [3H]-L-ornithine and [3H]-L-citrulline, but the stronger
effect on [3H]-L-citrulline formation may be explained by
an additional inhibitory effect on NOS. In agreement with
previous observations (14, 23), the formation of [3H]-L-citrulline was greatly enhanced and that of [3H]-L-ornithine
reduced when high levels of iNOS had been induced by
LPS, i.e., L-arginine was preferentially metabolized by
iNOS. There is evidence that NG-OH-L-arginine, the intermediate in the NO synthesis reaction, is released by iNOS
and inhibits arginase (38). Under these conditions poly-L-arginine again caused a marked reduction in the formation
of [3H]-L-citrulline, but on the contrary enhanced that of
[3H]-L-ornithine, although [3H]-L-ornithine remained below the level observed in control AM
. Because inhibition of high iNOS activity can favor L-arginine metabolism
by arginase (14), an inhibitory effect of poly-L-arginine on
iNOS is likely to be responsible for the increase of [3H]-L-ornithine in these experiments, but the additional inhibitory effect of poly-L-arginine on L-arginine transport keeps
[3H]-L-ornithine formation below the level of control AM
.
In conclusion, the present experiments show that different cationic proteins including MBP can exert inhibitory
effects on the cellular transport of L-arginine, and this can
result in a reduced substrate supply for L-arginine-dependent pathways such as NO synthesis, as shown in the
present paper for AM
. It appears likely that similar effects are of significance in other cells in which NO synthesis also depends on the uptake of L-arginine. There is evidence that NO synthesis in nitrergic neurons depends on
the acute supply of L-arginine (39, 40), and in the airways nitrigic nerves are an important inhibitory pathway (see
Reference 41). The different potencies of poly-L-lysine
and poly-L-arginine suggest that besides the charge of
these proteins, specific structures might also be of importance for the biologic effects of cationic proteins. Further,
poly-L-arginine, but not poly-L-lysine, appears to exert additional direct inhibitory effects on NOS.
| |
Footnotes |
|---|
Address correspondence to: K. Racké, Institute of Pharmacology and Toxicology, University of Bonn, Reuterstrasse 2b, D-53113 Bonn, Germany. E-mail: racke.kurt{at}uni-bonn.de
(Received in original form October 2, 1998 and in revised form March 8, 1999).
Abbreviations: alveolar macrophages, AM
; Dulbecco's modified Eagle's
medium, DMEM; Dulbecco's phosphate-buffered saline, D-PBS; eosinophilic cationic peptide, ECP; fetal calf serum, FCS; high-performance liquid chromatography, HPLC; inducible nitric oxide synthase, iNOS; lipopolysaccharides, LPS; major basic protein, MBP; nitric oxide, NO;
standard error of the mean, SEM.
Acknowledgments: This study was supported by the Deutsche Forschungsgemeinschaft (Ra 400/9-1). This paper contains part of the M.D. thesis of one author (J.H.) and the Ph.D. thesis of another author (J.M.). The authors are grateful to Dr. G. J. Gleich for the donation of major basic protein.
| |
References |
|---|
|
|
|---|
1. Gleich, G. J., C. R. Adolphson, and K. M. Leiferman. 1993. The biology of the eosinophilic leukocyte. Annu. Rev. Med. 44: 85-101 [Medline].
2. Corrigan, C. J., and A. B. Kay. 1992. T cells and eosinophils in the pathogenesis of asthma. Immunol. Today 13: 501-507 [Medline].
3. Bosquet, J. B., P. Chanez, J. Y. Lacoste, G. Barneon, N. Ghavanian, I. Enander, P. Venge, S. Ahlstedt, J. Simony-Lafontaine, P. Godard, and F. B. Michel. 1990. Eosinophilic inflammation in asthma. N. Engl. J. Med. 323: 1033-1039 [Abstract].
4. Durham, S. R., and A. B. Kay. 1985. Eosinophils, bronchial hyperreactivity and late-phase asthmatic reactions. Clin. Allergy 15: 411-418 [Medline].
5. Gundel, R. H., L. G. Letts, and G. J. Gleich. 1991. Human eosinophil major basic protein induces airway constriction and airway hyperresponsiveness in primates. J. Clin. Invest. 87: 1470-1473 .
6. Coyle, A. J., S. J. Ackerman, and C. G. Irvin. 1993. Cationic proteins induce airway hyperresponsiveness dependent on charge interactions. Am. Rev. Respir. Dis. 147: 896-900 [Medline].
7. Uchida, D. A., S. J. Ackerman, A. J. Coyle, G. L. Larsen, P. F. Weller, J. Freed, and C. G. Irvin. 1993. The effect of human eosinophil granule major basic protein on airway responsiveness in the rat in vivo: a comparison with polycations. Am. Rev. Respir. Dis. 147: 982-988 [Medline].
8. Nijkamp, F. P., H. Van der Linde, and G. Folkerts. 1993. Nitric oxide synthesis inhibitors induce airway hyperresponsiveness in the guinea pig in vivo and in vitro. Am. Rev. Respir. Dis. 148: 727-734 [Medline].
9. Folkerts, G., H. J. van der Linde, and F. P. Nijkamp. 1995. Virus-induced airway hyperresponsiveness in guinea pigs is related to a deficiency in nitric oxide. J. Clin. Invest. 95: 26-30 .
10. Deboer, J., H. Meurs, W. Coers, M. Koopal, A. E. Bottone, A. C. Visser, W. Timens, and J. Zaagsma. 1996. Deficiency of nitric oxide in allergen- induced airway hyperreactivity to contractile agonists after the early asthmatic reaction: an ex vivo study. Br. J. Pharmacol. 119: 1109-1116 [Medline].
11. Förstermann, U., and H. Kleinert. 1995. Nitric oxide synthase: expression and expressional control of the three isoforms. Naunyn Schmiedebergs Arch. Pharmacol. 352: 351-364 [Medline].
12. Closs, E. I.. 1996. CATs, a family of three distinct mammalian cationic amino acid transporters. Amino Acids 11: 193-208 .
13. Malandro, M. S., and M. S. Kilberg. 1996. Molecular biology of mammalian amino acid transporters. Annu. Rev. Biochem. 65: 305-336 [Medline].
14. Hey, C., I. Wessler, and K. Racké. 1995. Nitric oxide synthase activity is inducible in rat, but not rabbit alveolar macrophages, with a concomitant reduction in arginase activity. Naunyn Schmiedebergs Arch. Pharmacol. 351: 651-659 [Medline].
15. Wang, W. W., C. P. Jenkinson, J. M. Griscavage, R. M. Kern, N. S. Arabolos, R. E. Byrns, S. D. Cederbaum, and L. J. Ignarro. 1995. Co-induction of arginase and nitric oxide synthase in murine macrophages activated by lipopolysaccharide. Biochem. Biophys. Res. Commun. 210: 1009-1016 [Medline].
16.
Guo, F. H.,
H. R. De Raeve,
T. W. Rice,
D. J. Stuehr,
F. B. J. M. Thunnissen, and
S. C. Erzurum.
1995.
Continous nitric oxide synthesis by inducible
nitric oxide synthase in normal human airway epithelium in vivo.
Proc.
Natl. Acad. Sci. USA
92:
7809-7813
17.
Freitag, A.,
A. Reimann,
I. Wessler, and
K. Racké.
1996.
Effects of bacterial
lipopolysaccharides (LPS) and tumor necrosis factor-
(TNF-
) on rat tracheal epithelial cells in culture: morphology, proliferation and induction of
NO synthase.
Pulm. Pharmacol.
9:
149-156
[Medline].
18. Hammermann, R., N. Bliesener, J. Mössner, S. Klasen, H. Wiesinger, I. Wessler, and K. Racké. 1998. Inability of rat alveolar macrophages to recycle L-citrulline to L-arginine despite induction of argininosuccinate synthetase mRNA and protein, and inhibition of nitric oxide synthesis by exogenous L-citrulline. Naunyn Schmiedebergs Arch. Pharmacol. 358: 601-607 [Medline].
19. Barnes, P. J., and F. Y. Liew. 1995. Nitric oxide and asthmatic inflammation. Immunol. Today 16: 128-130 [Medline].
20. Brunn, G., C. Hey, I. Wessler, and K. Racké. 1997. Endogenous nitric oxide inhibits leukotriene B4 release from rat alveolar macrophages. Eur. J. Pharmacol. 326: 53-60 [Medline].
21. Racké, K., I. Wessler, and G. Brunn. 1996. Nitric oxide and asthmatic inflammation. Immunol. Today 17: 147-148 [Medline].
22. Hirschmann, J., C. Hey, R. Hammermann, J. G. Folkerts, F. P. Nijkamp, G. J. Gleich, I. Wessler, and K. Racké. 1998. Inhibition of L-arginine transport in rat and guinea-pig alveolar macrophages by poly-cationic peptides. Br. J. Pharmacol. 123: 42P . (Abstr.) .
23.
Hey, C.,
J. L. Boucher,
S. Vadon-Le Goff,
G. Ketterer,
I. Wessler, and
K. Racké.
1997.
Inhibition of arginase in rat and rabbit alveolar macrophages
by N
-hydroxy-D,L-indospicine, effects on L-arginine utilization by nitric
oxide synthase.
Br. J. Pharmacol.
121:
395-400
[Medline].
24.
Racké, K.,
C. Hey,
J. Mössner,
R. Hammermann,
C. Stichnote, and
I. Wessler.
1998.
Activation of L-arginine transport by protein kinase C in
rabbit, rat and mouse alveolar macrophages.
J. Physiol.
511:
813-825
25. Slifman, N. R., D. A. Loegering, D. J. McKean, and G. J. Gleich. 1986. Ribonuclease activity associated with human eosinophil-derived neurotoxin and eosinophil cationic protein. J. Immunol. 137: 2913-2917 [Abstract].
26. Frigas, E., D. A. Loegering, and G. L. Gleich. 1980. Cytotoxic effect of guinea-pig eosinophil major basic protein on tracheal epithelium. Lab. Invest. 42: 35-43 [Medline].
27. Motojima, S., E. Frigas, D. A. Loegering, and G. L. Gleich. 1989. Toxicity of eosinophil cationic proteins for guinea pig tracheal epithelium in vitro. Am. Rev. Respir. Dis. 139: 801-805 [Medline].
28. Frigas, E., and G. L. Gleich. 1986. The eosinophil and the pathophysiology of asthma. J. Allergy Clin. Immunol. 77: 527-537 [Medline].
29.
Coyle, A. J.,
W. Mitzner, and
C. G. Irvin.
1993.
Cationic proteins alter
smooth muscle function by an epithelium-dependent mechanism.
J. Appl.
Physiol.
74:
1761-1768
30. Coyle, A. J., S. J. Ackerman, D. Uchida, W. Mitzner, and C. G. Irvin. 1994. Role of cationic proteins in the airway. Hyperresponsiveness due to airway inflammation. Am. J. Respir. Crit. Care Med. 150: S63-S71 .
31. Prie, S., D. M. Conroy, G. J. Gleich, and P. Sirois. 1996. Eosinophils and neutrophils modify arachidonic acid-induced relaxation of guinea-pig trachea. Eur. J. Pharmacol. 317: 343-351 [Medline].
32. Coyle, A. J., F. Perretti, S. Manzini, and C. G. Irvin. 1994. Cationic protein-induced sensory nerve activation. J. Clin. Invest. 94: 2301-2306 .
33. Coyle, A. J., S. J. Ackerman, R. Burch, D. Proud, and C. G. Irvin. 1995. Human eosinophil-granule major basic protein and synthetic polycations induce airway hyperresponsiveness in vivo dependent on bradykinin generation. J. Clin. Invest. 95: 1735-1740 .
34. Costello, R. W., B. H. Schofield, G. M. Kephart, G. J. Gleich, D. B. Jacoby, and A. D. Fryer. 1997. Localization of eosinophils to airway nerves and effect on neuronal M-2 muscarinic receptor function. Am. J. Physiol. (Lung Cell. Mol. Physiol.) 17: L93-L103 .
35. Van Scott, M. R., M. D. Smith, C. A. Welch, C. Bentzel, and W. J. Metzger. 1996. Bioelectric response of human nasal epithelial cells to polycationic protein. Am. J. Physiol. (Lung Cell. Mol. Physiol.) 15: L159-L165 .
36. Racké, K., C. Hey, C. Stichnote, A. Freitag, M. Brüss, H. Bönisch, and I. Wessler. 1997. Characterization of L-arginine transport in rat tracheal epithelial cells in culture. Naunyn Schmiedebergs Arch. Pharmacol. 356: R23 . (Abstr.) .
37. Tabor, C. W., and H. Tabor. 1984. Polyamines. Annu. Rev. Biochem. 53: 749-790 [Medline].
38. Hecker, M., H. Nematollahi, C. Hey, R. Busse, and K. Racké. 1995. Inhibition of arginase by NG-hydroxy-L-arginine in alveolar macrophages: implications for the utilization of L-arginine for nitric oxide synthesis. FEBS Lett. 359: 251-254 [Medline].
39. Do, K. Q., B. Benz, and G. Grima. 1996. Nitric oxide precursor arginine and S-nitrosoglutathione in synaptic and glial function. Neurochem. Int. 29: 213-224 [Medline].
40. Grima, G., K. Q. Do, and B. Benz. 1997. Glutamate-induced release of the nitric oxide precursor, arginine, from glial cells. Eur. J. Neurosci. 9: 2248-2258 [Medline].
41. Barnes, P. J.. 1993. Nitric oxide and airways. Eur. Respir. J. 6: 163-165 [Medline].
This article has been cited by other articles:
![]() |
H. Maarsingh, B. E. Bossenga, I. S. T. Bos, H. H. Volders, J. Zaagsma, and H. Meurs L-Arginine deficiency causes airway hyperresponsiveness after the late asthmatic reaction Eur. Respir. J., July 1, 2009; 34(1): 191 - 199. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. North, N. Khanna, P. A. Marsden, H. Grasemann, and J. A. Scott Functionally important role for arginase 1 in the airway hyperresponsiveness of asthma Am J Physiol Lung Cell Mol Physiol, June 1, 2009; 296(6): L911 - L920. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Meurs, R. Gosens, and J. Zaagsma Airway hyperresponsiveness in asthma: lessons from in vitro model systems and animal models Eur. Respir. J., August 1, 2008; 32(2): 487 - 502. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Yeramian, L. Martin, N. Serrat, L. Arpa, C. Soler, J. Bertran, C. McLeod, M. Palacin, M. Modolell, J. Lloberas, et al. Arginine Transport via Cationic Amino Acid Transporter 2 Plays a Critical Regulatory Role in Classical or Alternative Activation of Macrophages J. Immunol., May 15, 2006; 176(10): 5918 - 5924. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. E. King, M. E. Rothenberg, and N. Zimmermann Arginine in Asthma and Lung Inflammation J. Nutr., October 1, 2004; 134(10): 2830S - 2836S. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Endo, S. Oyadomari, Y. Terasaki, M. Takeya, M. Suga, M. Mori, and T. Gotoh Induction of arginase I and II in bleomycin-induced fibrosis of mouse lung Am J Physiol Lung Cell Mol Physiol, August 1, 2003; 285(2): L313 - L321. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Hammermann, M. D. M. Dreißig, J. Mössner, M. Fuhrmann, L. Berrino, M. Göthert, and K. Racké Nuclear Factor-kappa B Mediates Simultaneous Induction of Inducible Nitric-Oxide Synthase and Up-Regulation of the Cationic Amino Acid Transporter CAT-2B in Rat Alveolar Macrophages Mol. Pharmacol., April 13, 2001; 58(6): 1294 - 1302. [Abstract] [Full Text] |
||||
![]() |
F. H. Guo, S. A. A. Comhair, S. Zheng, R. A. Dweik, N. T. Eissa, M. J. Thomassen, W. Calhoun, and S. C. Erzurum Molecular Mechanisms of Increased Nitric Oxide (NO) in Asthma: Evidence for Transcriptional and Post-Translational Regulation of NO Synthesis J. Immunol., June 1, 2000; 164(11): 5970 - 5980. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Mark Madison and C. M. Schramm Cationic Proteins and Bronchial Hyperresponsiveness Am. J. Respir. Cell Mol. Biol., May 1, 2000; 22(5): 513 - 516. [Full Text] |
||||
![]() |
S. P. Sanders Nitric Oxide in Asthma . Pathogenic, Therapeutic, or Diagnostic? Am. J. Respir. Cell Mol. Biol., August 1, 1999; 21(2): 147 - 149. [Full Text] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Proc. Am. Thorac. Soc. | Am. J. Respir. Crit. Care Med. |